When All Else Fails : The Use of Electroconvulsive Therapy for Conditions Other than Major Depressive Episode - 10/08/18
Résumé |
The use of electroconvulsive therapy (ECT) for those suffering from major depressive disorder is well-evidenced, time-honored, and recognized by most treatment guidelines. However, since its inception ECT has been used by practitioners for a broader range of neuropsychiatric conditions. This article reviews the highly variable evidence supporting the use of ECT in conditions other than depression, such as schizophrenia, bipolar manic states, catatonia, Parkinson disease, and post-traumatic stress disorder.
Le texte complet de cet article est disponible en PDF.Keywords : Electroconvulsive therapy, Indications, Schizophrenia, Bipolar disorder, Mania, Post-traumatic stress disorder, Catatonia
Plan
Dr P.B. Rosenquist discloses current research funding from NIMH (R01MH09S776A1), American Foundation for Suicide Prevention, Lumosity Corporation (66324S-13), Merck (8S0073-9), ALS Association, GlaxoSmithKline, Harvard Stem Cell Institute, Neurologic Clinical Research Institute (701419-18), and MECTA Corporation (72200S-2). Dr N.A. Youssef discloses current research supported by American Foundation for Suicide Prevention (DIG-0-087-13), Merck, MECTA Corporation, ABR Corporation, and Veterans Administration. Dr S. Surya has no disclosures. Dr W.V. McCall discloses current research support from NIMH, American Foundation for Suicide Prevention, Merck, and MECTA Corporation. |
Vol 41 - N° 3
P. 355-371 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?